Active Ingredient: CIPROFLOXACIN
Proprietary Name: OTIPRIO
Dosage Form; Route of Administration: INJECTABLE, SUSPENSION; OTIC
Strength: 6% (60MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N207986
Product Number: 001
Approval Date: Dec 10, 2015
Applicant Holder Full Name: ALK-ABELLO INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
